Dermoscopy and Histopathology Patterns in Pigmented Skin Lesions
Official title: Dermoscopic and Histopathological Patterns of Pigmented Skin Lesions: A Cross-sectional Analytical Study.
Run by Sohag University · NCT07863076 · Data updated 2026-11-12
This study tests how dermoscopic patterns align with clinical and histopathological diagnoses in people with pigmented skin lesions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Year and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Status | Recruiting |
| Started | October 1, 2026 |
| Main results expected | October 31, 2027 |
| Study ends | December 2027 |
| Registry record updated | October 7, 2026 |
| Trial ID | NCT07863076 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with clinically diagnosed or suspected pigmented skin lesions across all body sites who can provide usable dermoscopic images and, when possible, histopathology data.
✕Probably not a fit
Patients with lesions that remain benign or where histopathology is not available may not experience a diagnostic benefit from dermoscopy alone.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study describes the characteristic dermoscopic features of pigmented skin lesions, including melanocytic and non-melanocytic types, seen at Sohag University Hospitals. It aims to correlate dermoscopic findings with clinical evaluations and available histopathology to improve diagnostic understanding. The project also evaluates how well dermoscopy distinguishes benign from malignant pigmented skin lesions. Participants include individuals with clinically diagnosed or suspected pigmented nevi, seborrheic keratosis, pigmented actinic keratosis, pigmented basal cell carcinoma, and suspected melanoma, across facial, acral, mucosal, and trunk sites. Exclusion criteria include poor-quality dermoscopic images and lesions where histopathology cannot be obtained.
Why it matters
Potential benefit: If successful, dermoscopy could help clinicians more accurately differentiate benign from malignant pigmented lesions, potentially guiding management and biopsy decisions.
How similar studies have gone: Previous work has shown that dermoscopy can improve diagnostic accuracy for pigmented skin lesions in other settings, supporting the potential usefulness of this approach here.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Patients with clinically diagnosed or suspected pigmented skin lesions including; pigmented nevi (typical and atypical), seborrheic keratosis, pigmented actinic keratosis, pigmented BCC, suspected melanoma * All facial, acral, mucosal and trunk pigmented lesions will be included Exclusion Criteria: * • Poor quality dermoscopic images that are unsuitable for interpretation. * Lesions with difficulty in obtaining histopathological specimens
Where it's running
-
Sohag University Hospitals
Sohag, Egypt Recruiting
Study contacts
- Study coordinator: Doaa Gaber Abdelbaset, Lecturer
- Email: doaaabdelbaset23@gmail.com
- Phone: 01022330810
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Trauma registry at Sohag University Hospital
This study tests the creation of a trauma registry in the emergency department to collect data on injured adults admitted with polytrauma at Sohag University Hospital.
-
Prevalence of Myocardial Bridging and its relation to Coronary Plaques on MDCT
This study tests how common myocardial bridging is and whether it relates to coronary plaque in patients undergoing coronary CT angiography.
-
Septoplasty: see if it changes headache symptoms
This study tests whether septoplasty can change headache severity in adults with septal deviation and headache.
-
Predicting SLE Flares with Patient Reports and Machine Learning
Aims to test a low-cost, patient-reported outcome–based machine learning tool to see if it can detect lupus flares early and support care, especially in settings with limited resources.
-
Is geographic mismatch linked to short-term major heart problems after long drug-eluting stent placement?
This study checks whether geographic mismatch can predict short-term major adverse cardiovascular events after a long drug-eluting stent is placed in the coronary arteries.
-
Biomarkers to predict no-reflow after opening the heart’s artery in STEMI patients
This study tests whether immune-inflammatory and metabolic biomarkers can predict coronary no-reflow after primary PCI in adults with STEMI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.